Patent · US Active

Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells

US12065671B2 · kind B2 · utility

0Cited by

5References

30Claims

0Family size

Assignees

The United States of America, as represented by the Secretary, Department of Health and Human Services · US
FUJIFILM Cellular Dynamics, Inc. · US

Inventors

Kapil Bharti · Potomac, US
Lucas Chase · Madison, US
Feng Xuezhu · Madison, US
Balendu Shekhar Jha · Bethesda, US

Key dates

Filing date	Jul 16, 2020
Grant date	Aug 20, 2024
Priority date	—
Expiry date	Jul 8, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2533/52
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Provided herein are methods of producing an RPE cell population from a starting cell suspension, such as a single cell suspension, of pluripotent stem cells (PSCs). Such a method may comprise culturing the starting single cell suspension of PSCs in differentiation media to produce human RPE cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.